During the past decade, Genesis Cancer and Blood Institute conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Genesis Cancer and Blood Institute" #1 collaborator was "Bristol-Myers Squibb" with 1 trials as a collaborator, "Gilead Sciences" with 1 trials as a collaborator, "Merck Sharp & Dohme LLC" with 1 trials as a collaborator and "Parexel" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Genesis Cancer and Blood Institute" are "Triple Negative Breast Cancer" (2 trials), "Advanced Upper Gastrointestinal Tract Adenocarcinoma" (1 trials), "Non-small Cell Lung Cancer (NSCLC)" (1 trials), "PD-L1 Negative" (1 trials) and "PD-L1 Positive" (1 trials). Many other conditions were trialed in "Genesis Cancer and Blood Institute" in a lesser frequency.

Most popular intervention types in "Genesis Cancer and Blood Institute" are "Drug" (5 trials). Other intervention types were less common.

The name of intervention was led by "Carboplatin" (2 trials), "Gemcitabine" (2 trials), "Nivolumab" (2 trials), "Paclitaxel" (2 trials) and "Sacituzumab Govitecan-hziy" (2 trials). Other intervention names were less common.

The vast majority of trials in "Genesis Cancer and Blood Institute" are 5 trials for "All" genders.

Currently, there are NaN active trials in "Genesis Cancer and Blood Institute". undefined are not yet recruiting, 4 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Genesis Cancer and Blood Institute, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Genesis Cancer and Blood Institute, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".

Genesis Cancer and Blood Institute has several departments that took part in Clinical trials: "Genesis Cancer Center" - 50 trials